alpha-Glucosidase Inhibitor [EPC]

alpha-Glucosidase Inhibitor [EPC] was reported 4888 times

Drugs of the alpha-Glucosidase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MAST CELL DEGRANULATION PRESENT 7 0.3684
1 NEUROGLYCOPENIA 25 0.2273
2 EOSINOPHIL COUNT NORMAL 3 0.2143
3 PERIPHERAL ARTERY HAEMATOMA 6 0.2143
4 CEREBRAL REPERFUSION INJURY 3 0.1250
5 INTESTINAL TRANSIT TIME ABNORMAL 6 0.1091
6 ALCOHOLIC KETOACIDOSIS 3 0.0769
7 HYPEROXALURIA 13 0.0756
8 PERIPHERAL CIRCULATORY FAILURE 24 0.0585
9 PORTAL VENOUS GAS 15 0.0413
10 PULMONARY TUMOUR THROMBOTIC MICROANGIOPATHY 3 0.0390
11 DIABETIC KETOSIS 14 0.0368
12 ANTI-INSULIN ANTIBODY POSITIVE 7 0.0335
13 ANTI-INSULIN ANTIBODY INCREASED 3 0.0323
14 HYPOGLYCAEMIC ENCEPHALOPATHY 12 0.0308
15 REPERFUSION INJURY 4 0.0290
16 MULTIPLE DRUG THERAPY 21 0.0279
17 ACETONAEMIA 7 0.0278
18 HYPOGLYCAEMIC COMA 70 0.0243
19 POSTPRANDIAL HYPOGLYCAEMIA 4 0.0214
20 CARDIOSPASM 10 0.0179
21 KETOSIS 19 0.0175
22 PNEUMATOSIS INTESTINALIS 49 0.0172
23 INSULIN AUTOIMMUNE SYNDROME 6 0.0168
24 DIABETIC VASCULAR DISORDER 4 0.0161
25 IN-STENT CORONARY ARTERY RESTENOSIS 3 0.0155
26 HYPOCAPNIA 6 0.0144
27 SCROTAL INFECTION 3 0.0143
28 HYPEROSMOLAR STATE 4 0.0139
29 PALMOPLANTAR KERATODERMA 10 0.0138
30 GASTRIC POLYPS 26 0.0115
31 RETINITIS PIGMENTOSA 3 0.0115
32 BLOOD CHOLESTEROL DECREASED 21 0.0113
33 CONTRAST ENCEPHALOPATHY 3 0.0109
34 DIABETIC METABOLIC DECOMPENSATION 15 0.0108
35 ALBUMIN URINE PRESENT 4 0.0105
36 ASPERGILLOMA 3 0.0094
37 POSTERIOR CAPSULE OPACIFICATION 3 0.0087
38 PSEUDOSTROKE 3 0.0087
39 GLUCOSE URINE PRESENT 10 0.0079
40 STUPOR 25 0.0078
41 SKIN TURGOR DECREASED 3 0.0077
42 DIABETES MELLITUS INADEQUATE CONTROL 135 0.0076
43 HYPOGLYCAEMIA 357 0.0074
44 DIABETIC NEPHROPATHY 16 0.0073
45 PSEUDOLYMPHOMA 4 0.0072
46 VANISHING BILE DUCT SYNDROME 8 0.0072
47 URINE KETONE BODY PRESENT 11 0.0070
48 RETICULOCYTE COUNT DECREASED 3 0.0070
49 HYPOPROTEINAEMIA 13 0.0068
50 HYPERLEUKOCYTOSIS 6 0.0068
51 RENAL CANCER METASTATIC 5 0.0065
52 BLOOD OSMOLARITY DECREASED 4 0.0064
53 ATRIOVENTRICULAR BLOCK FIRST DEGREE 27 0.0062
54 HYPERGAMMAGLOBULINAEMIA 3 0.0062
55 MONOPARESIS 11 0.0061
56 QUADRIPARESIS 10 0.0060
57 INCISION SITE PAIN 7 0.0060
58 MARASMUS 9 0.0059
59 CHRONIC GASTRITIS 13 0.0058
60 LABELLED DRUG-DRUG INTERACTION ISSUE 8 0.0055
61 DYSLALIA 4 0.0055
62 LIP EROSION 4 0.0055
63 PRESBYOPIA 3 0.0054
64 SKIN TEST POSITIVE 5 0.0054
65 ATRIAL TACHYCARDIA 11 0.0052
66 QRS AXIS ABNORMAL 4 0.0052
67 HYPOCHLORAEMIA 6 0.0051
68 CORONARY ARTERY RESTENOSIS 3 0.0050
69 MUCOSAL DRYNESS 10 0.0050
70 EUGLYCAEMIC DIABETIC KETOACIDOSIS 20 0.0048
71 ADRENAL MASS 4 0.0048
72 PRURITUS GENITAL 11 0.0047
73 PANCREATITIS CHRONIC 11 0.0046
74 HYPERMAGNESAEMIA 3 0.0046
75 LACUNAR INFARCTION 11 0.0046
76 GASTROINTESTINAL MUCOSAL DISORDER 3 0.0046
77 CYTOLYTIC HEPATITIS 15 0.0045
78 BRADYKINESIA 25 0.0042
79 DIABETIC RETINOPATHY 14 0.0041
80 CELL DEATH 8 0.0040
81 LACTIC ACIDOSIS 126 0.0039
82 KETOACIDOSIS 29 0.0039
83 PEMPHIGOID 29 0.0038
84 BLOOD CREATINE INCREASED 17 0.0038
85 PEPTIC ULCER 12 0.0036
86 CEREBRAL INFARCTION 86 0.0035
87 SERONEGATIVE ARTHRITIS 4 0.0035
88 BLOOD LACTIC ACID INCREASED 18 0.0034
89 UPPER RESPIRATORY TRACT INFLAMMATION 4 0.0033
90 BLOOD IMMUNOGLOBULIN E INCREASED 8 0.0033
91 MUSCLE NECROSIS 3 0.0033
92 DIABETIC KETOACIDOSIS 78 0.0032
93 PROTHROMBIN LEVEL DECREASED 3 0.0032
94 MICTURITION DISORDER 11 0.0032
95 SEDATION COMPLICATION 8 0.0031
96 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 4 0.0031
97 RED BLOOD CELLS URINE POSITIVE 3 0.0031
98 DUODENAL PERFORATION 3 0.0031
99 ANION GAP INCREASED 4 0.0030
100 HYPERLACTACIDAEMIA 8 0.0030
101 TOXIC ENCEPHALOPATHY 15 0.0030
102 VASCULAR STENT THROMBOSIS 6 0.0029
103 BRAIN STEM INFARCTION 3 0.0029
104 RECTAL CANCER 9 0.0029
105 CAROTID ARTERIOSCLEROSIS 3 0.0029
106 PARKINSONISM 28 0.0029
107 BLOOD GLUCOSE ABNORMAL 53 0.0029
108 VASCULAR PURPURA 4 0.0029
109 HYPOPERFUSION 3 0.0029
110 DIABETIC COMPLICATION 7 0.0027
111 PNEUMOPERITONEUM 5 0.0027
112 HYPERKALAEMIA 94 0.0027
113 AUTOIMMUNE THYROIDITIS 10 0.0026
114 DIABETIC NEUROPATHY 13 0.0026
115 APLASIA PURE RED CELL 9 0.0026
116 SLEEP TERROR 11 0.0026
117 PROTEIN URINE PRESENT 13 0.0026
118 DAYDREAMING 4 0.0026
119 MELAENA 57 0.0026
120 EPIDIDYMITIS 3 0.0026
121 IMMUNE-MEDIATED HEPATIC DISORDER 5 0.0026
122 TENSION HEADACHE 11 0.0026
123 COLITIS MICROSCOPIC 12 0.0025
124 HYPOGLYCAEMIC UNCONSCIOUSNESS 5 0.0025
125 HYPERGLYCAEMIA 92 0.0025
126 HYPOTONIA 25 0.0025
127 CARDIAC DISCOMFORT 5 0.0025
128 CAROTID ARTERY OCCLUSION 9 0.0025
129 SKULL FRACTURE 4 0.0025
130 BRADYARRHYTHMIA 4 0.0024
131 BLOOD PRESSURE SYSTOLIC DECREASED 11 0.0024
132 GASTROINTESTINAL NECROSIS 7 0.0024
133 GASTRITIS EROSIVE 11 0.0024
134 MOTOR DYSFUNCTION 24 0.0024
135 ANGINA UNSTABLE 15 0.0023
136 PAPILLARY THYROID CANCER 4 0.0023
137 DIABETIC FOOT 7 0.0023
138 HEPATIC FUNCTION ABNORMAL 85 0.0023
139 GASTROINTESTINAL OEDEMA 4 0.0023
140 INITIAL INSOMNIA 23 0.0022
141 LYMPHOCYTE PERCENTAGE DECREASED 3 0.0022
142 POLYMYALGIA RHEUMATICA 7 0.0022
143 BLOOD GLUCOSE FLUCTUATION 24 0.0022
144 HYPERURICAEMIA 9 0.0022
145 MUSCLE RIGIDITY 26 0.0022
146 BILIRUBIN CONJUGATED INCREASED 5 0.0021
147 PERIPHERAL ARTERY OCCLUSION 3 0.0021
148 PSYCHOMOTOR RETARDATION 6 0.0021
149 GLYCOSYLATED HAEMOGLOBIN INCREASED 53 0.0021
150 HAEMODYNAMIC INSTABILITY 16 0.0021
151 BLOOD UREA INCREASED 35 0.0021
152 HIATUS HERNIA 27 0.0021
153 HEPATITIS FULMINANT 6 0.0020
154 CEREBRAL ATROPHY 8 0.0020
155 GASTROINTESTINAL WALL THICKENING 3 0.0020
156 TYPE I HYPERSENSITIVITY 7 0.0020
157 RETINAL ARTERY OCCLUSION 5 0.0020
158 SHOCK HAEMORRHAGIC 16 0.0020
159 ISCHAEMIC CARDIOMYOPATHY 6 0.0020
160 CALCULUS URINARY 3 0.0019
161 QUADRIPLEGIA 4 0.0019
162 COAGULATION TIME PROLONGED 3 0.0019
163 ELECTROCARDIOGRAM T WAVE ABNORMAL 3 0.0019
164 GASTROINTESTINAL STOMA COMPLICATION 3 0.0019
165 ALTERED STATE OF CONSCIOUSNESS 40 0.0018
166 LEUKOCYTOCLASTIC VASCULITIS 3 0.0018
167 HEPATITIS CHOLESTATIC 11 0.0018
168 RETINAL HAEMORRHAGE 13 0.0018
169 VITREOUS HAEMORRHAGE 5 0.0018
170 MYOCARDIAL NECROSIS MARKER INCREASED 3 0.0018
171 CORONARY ARTERY STENOSIS 9 0.0018
172 DIVERTICULUM INTESTINAL HAEMORRHAGIC 4 0.0018
173 POLYDIPSIA 7 0.0018
174 ANURIA 15 0.0017
175 THYROIDITIS 5 0.0017
176 MIXED LIVER INJURY 5 0.0017
177 CARDIAC FAILURE ACUTE 11 0.0016
178 MYOPATHY 14 0.0016
179 DIASTOLIC DYSFUNCTION 5 0.0016
180 HAEMORRHAGIC ANAEMIA 7 0.0016
181 HYPOMAGNESAEMIA 22 0.0016
182 MECHANICAL VENTILATION 3 0.0016
183 ACIDOSIS 12 0.0016
184 HEMIPLEGIA 13 0.0016
185 BENIGN PROSTATIC HYPERPLASIA 8 0.0015
186 HYPERTRIGLYCERIDAEMIA 9 0.0015
187 RENAL TUBULAR NECROSIS 15 0.0015
188 EXFOLIATIVE RASH 4 0.0015
189 LUNG OPACITY 4 0.0015
190 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 5 0.0015
191 BLOOD POTASSIUM ABNORMAL 4 0.0015
192 LIPIDS INCREASED 3 0.0015
193 HYPOCALCAEMIA 28 0.0015
194 BLOOD POTASSIUM INCREASED 24 0.0015
195 SUBARACHNOID HAEMORRHAGE 15 0.0015
196 HEPATIC CYST 5 0.0015
197 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 6 0.0015
198 DRUG ERUPTION 26 0.0015
199 INTESTINAL ISCHAEMIA 8 0.0015
200 INSULIN RESISTANCE 3 0.0014
201 RENAL FAILURE ACUTE 61 0.0014
202 CAROTID ARTERY STENOSIS 5 0.0014
203 PANCREATITIS ACUTE 32 0.0014
204 HYPERLIPIDAEMIA 17 0.0014
205 DEVICE CONNECTION ISSUE 3 0.0014
206 STAPHYLOCOCCAL SEPSIS 7 0.0014
207 HEPATIC NEOPLASM MALIGNANT 3 0.0014
208 CARDIAC FAILURE CHRONIC 6 0.0014
209 PYODERMA GANGRENOSUM 5 0.0014
210 DYSLIPIDAEMIA 7 0.0014
211 ORTHOSTATIC HYPOTENSION 24 0.0014
212 METABOLIC ACIDOSIS 44 0.0014
213 SKIN WARM 8 0.0014
214 HENOCH-SCHONLEIN PURPURA 3 0.0014
215 DRUG-INDUCED LIVER INJURY 43 0.0014
216 ENDOMETRIAL CANCER 3 0.0014
217 ARTERIOSCLEROSIS CORONARY ARTERY 9 0.0014
218 PROTHROMBIN TIME PROLONGED 8 0.0013
219 METABOLIC ENCEPHALOPATHY 4 0.0013
220 NORMOCHROMIC NORMOCYTIC ANAEMIA 4 0.0013
221 REBOUND ACID HYPERSECRETION 4 0.0013
222 CORONARY ARTERY DISEASE 40 0.0013
223 DYSCHEZIA 4 0.0013
224 NEUROLOGICAL DECOMPENSATION 3 0.0013
225 CHOLANGITIS 8 0.0013
226 URINARY RETENTION 42 0.0013
227 BILE DUCT STONE 4 0.0013
228 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
229 BLOOD GLUCOSE INCREASED 231 0.0012
230 HEART INJURY 3 0.0012
231 ELECTROLYTE IMBALANCE 14 0.0012
232 NEPHRITIS 4 0.0012
233 DYSURIA 44 0.0012
234 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6 0.0012
235 SEDATION 31 0.0012
236 BUNDLE BRANCH BLOCK LEFT 5 0.0012
237 AORTIC VALVE INCOMPETENCE 5 0.0012
238 GAMMA-GLUTAMYLTRANSFERASE INCREASED 26 0.0012
239 ARTERIOSCLEROSIS 11 0.0012
240 AORTIC ARTERIOSCLEROSIS 3 0.0012
241 WOUND COMPLICATION 4 0.0012
242 HEPATITIS TOXIC 3 0.0012
243 POSTMENOPAUSAL HAEMORRHAGE 3 0.0011
244 RHABDOMYOLYSIS 48 0.0011
245 EMBOLIC STROKE 4 0.0011
246 HYPONATRAEMIA 64 0.0011
247 LARYNGEAL OEDEMA 7 0.0011
248 RENAL IMPAIRMENT 95 0.0011
249 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
250 VITAMIN D DEFICIENCY 11 0.0011
251 ILEUS 14 0.0011
252 ILEUS PARALYTIC 5 0.0011
253 FACIAL PAIN 10 0.0011
254 CARDIOGENIC SHOCK 16 0.0011
255 BLOOD SODIUM INCREASED 3 0.0011
256 BEHAVIOUR DISORDER 6 0.0011
257 HYPOKALAEMIA 51 0.0011
258 BLOOD GLUCOSE DECREASED 53 0.0011
259 POLYURIA 9 0.0011
260 CARDIAC FAILURE 88 0.0011
261 DRUG INTERACTION 173 0.0011
262 ISCHAEMIA 5 0.0011
263 IMMUNE-MEDIATED ENTEROCOLITIS 4 0.0011
264 DRUG LEVEL INCREASED 18 0.0011
265 BLOOD CREATINE PHOSPHOKINASE INCREASED 31 0.0011
266 LYMPHOCYTE COUNT DECREASED 19 0.0011
267 ERYTHEMA MULTIFORME 10 0.0011
268 ACUTE KIDNEY INJURY 163 0.0011
269 SUBDURAL HAEMATOMA 15 0.0010
270 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
271 LIPASE INCREASED 8 0.0010
272 LUNG CANCER METASTATIC 3 0.0010
273 BLOOD URIC ACID INCREASED 6 0.0010
274 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
275 INTERNATIONAL NORMALISED RATIO INCREASED 29 0.0010
276 BLOOD LACTATE DEHYDROGENASE INCREASED 16 0.0010
277 TRICUSPID VALVE INCOMPETENCE 8 0.0010
278 HEMIPARESIS 17 0.0010
279 HYPERNATRAEMIA 5 0.0010
280 DERMATITIS EXFOLIATIVE 5 0.0010
281 MUSCLE HAEMORRHAGE 4 0.0010
282 CEREBROVASCULAR DISORDER 3 0.0010
283 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
284 DUODENAL ULCER 7 0.0010
285 LIVER DISORDER 44 0.0010
286 PROSTATITIS 3 0.0010
287 ALANINE AMINOTRANSFERASE INCREASED 60 0.0010
288 CARDIOMEGALY 12 0.0010
289 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
290 CACHEXIA 5 0.0010
291 CEREBRAL ISCHAEMIA 5 0.0010
292 GENERALISED OEDEMA 12 0.0010
293 SPINAL STENOSIS 4 0.0010
294 MYOCARDIAL ISCHAEMIA 11 0.0010
295 ASPARTATE AMINOTRANSFERASE INCREASED 51 0.0010
296 PULSELESS ELECTRICAL ACTIVITY 4 0.0010
297 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
298 SERUM FERRITIN INCREASED 5 0.0009
299 HYPERPYREXIA 4 0.0009
300 VASCULITIS 11 0.0009
301 RASH MACULO-PAPULAR 21 0.0009
302 LUNG NEOPLASM 4 0.0009
303 SKIN EROSION 3 0.0009
304 SINUS BRADYCARDIA 9 0.0009
305 BLOOD ALKALINE PHOSPHATASE INCREASED 23 0.0009
306 HEPATIC LESION 4 0.0009
307 HEPATIC NEOPLASM 3 0.0009
308 DIVERTICULUM INTESTINAL 4 0.0009
309 TUBULOINTERSTITIAL NEPHRITIS 17 0.0009
310 GASTRIC ULCER HAEMORRHAGE 5 0.0009
311 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
312 DEMENTIA 25 0.0009
313 MALNUTRITION 10 0.0009
314 TOXIC SKIN ERUPTION 9 0.0009
315 MYOSITIS 8 0.0009
316 BLOOD ALBUMIN DECREASED 7 0.0009
317 GASTROINTESTINAL DISORDER 79 0.0009
318 ACUTE MYOCARDIAL INFARCTION 26 0.0009
319 DIABETES MELLITUS 67 0.0009
320 BLOOD PRESSURE DECREASED 58 0.0009
321 PNEUMONIA BACTERIAL 8 0.0009
322 SHOCK 20 0.0009
323 BLOOD CREATININE ABNORMAL 3 0.0009
324 BLOOD CREATININE INCREASED 56 0.0009
325 CHRONIC KIDNEY DISEASE 65 0.0009
326 UNRESPONSIVE TO STIMULI 22 0.0009
327 NECROTISING FASCIITIS 3 0.0009
328 VENTRICULAR TACHYCARDIA 14 0.0008
329 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
330 ANGINA PECTORIS 24 0.0008
331 HAEMATEMESIS 21 0.0008
332 LIVER TRANSPLANT 3 0.0008
333 BLOOD BILIRUBIN INCREASED 22 0.0008
334 HYPOPHOSPHATAEMIA 6 0.0008
335 PANCREATIC DISORDER 4 0.0008
336 CEREBRAL DISORDER 6 0.0008
337 TRANSAMINASES INCREASED 18 0.0008
338 HEPATOTOXICITY 18 0.0008
339 HEPATIC STEATOSIS 15 0.0008
340 INJECTION SITE INFLAMMATION 4 0.0008
341 EOSINOPHILIA 14 0.0008
342 BRAIN INJURY 8 0.0008
343 C-REACTIVE PROTEIN INCREASED 29 0.0008
344 COLD SWEAT 14 0.0008
345 PLEURAL EFFUSION 48 0.0008
346 FEMORAL NECK FRACTURE 4 0.0008
347 LIVER INJURY 19 0.0008
348 LUNG INFECTION 12 0.0008
349 HYPOALBUMINAEMIA 6 0.0008
350 HEPATITIS ACUTE 5 0.0008
351 BLOOD PRESSURE SYSTOLIC INCREASED 15 0.0008
352 PNEUMONIA FUNGAL 3 0.0008
353 CHOLECYSTITIS 9 0.0008
354 RENAL CYST 6 0.0008
355 OSTEOPOROSIS 31 0.0008
356 AGRANULOCYTOSIS 14 0.0008
357 AZOTAEMIA 3 0.0008
358 NEPHROPATHY 7 0.0007
359 INTRACRANIAL ANEURYSM 3 0.0007
360 OEDEMA PERIPHERAL 91 0.0007
361 INTERSTITIAL LUNG DISEASE 36 0.0007
362 JAUNDICE 20 0.0007
363 TYPE 2 DIABETES MELLITUS 25 0.0007
364 COLITIS ISCHAEMIC 5 0.0007
365 GASTRIC ULCER 14 0.0007
366 HAEMATURIA 25 0.0007
367 GASTROINTESTINAL PERFORATION 3 0.0007
368 VENTRICULAR FIBRILLATION 8 0.0007
369 ACUTE PULMONARY OEDEMA 4 0.0007
370 CHOLECYSTITIS ACUTE 4 0.0007
371 POOR PERIPHERAL CIRCULATION 3 0.0007
372 PURULENT DISCHARGE 3 0.0007
373 MUSCLE TWITCHING 16 0.0007
374 ENTEROCOLITIS 4 0.0007
375 OCULAR ICTERUS 3 0.0007
376 ANOSMIA 10 0.0007
377 MONOPLEGIA 3 0.0007
378 INTESTINAL OBSTRUCTION 26 0.0007
379 SEPTIC SHOCK 30 0.0007
380 RALES 4 0.0007
381 PRODUCT PRESCRIBING ISSUE 15 0.0007
382 LIVER FUNCTION TEST ABNORMAL 20 0.0007
383 URINE OUTPUT DECREASED 6 0.0007
384 NEUTROPHIL COUNT INCREASED 7 0.0007
385 BLOOD TRIGLYCERIDES INCREASED 12 0.0007
386 CHOLESTASIS 13 0.0007
387 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
388 BACTERAEMIA 8 0.0007
389 VENTRICULAR EXTRASYSTOLES 7 0.0007
390 ATAXIA 8 0.0007
391 ISCHAEMIC STROKE 12 0.0007
392 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
393 CORONARY ARTERY OCCLUSION 9 0.0007
394 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 36 0.0007
395 EAR DISORDER 3 0.0007
396 HYPERTHERMIA 5 0.0007
397 PERICARDITIS 11 0.0007
398 LUMBAR VERTEBRAL FRACTURE 3 0.0007
399 TRANSIENT ISCHAEMIC ATTACK 22 0.0007
400 WHITE BLOOD CELL COUNT INCREASED 25 0.0007
401 RENAL FAILURE CHRONIC 5 0.0006
402 SYNCOPE 65 0.0006
403 LOCALISED OEDEMA 3 0.0006
404 NEPHROGENIC ANAEMIA 3 0.0006
405 RENAL FUNCTION TEST ABNORMAL 3 0.0006
406 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0006
407 CIRCULATORY COLLAPSE 11 0.0006
408 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
409 APPENDICITIS 6 0.0006
410 BRADYCARDIA 34 0.0006
411 ATRIAL FIBRILLATION 62 0.0006
412 INJECTION SITE NODULE 7 0.0006
413 DERMATITIS ALLERGIC 8 0.0006
414 HYPERCHOLESTEROLAEMIA 6 0.0006
415 ATELECTASIS 6 0.0006
416 HAEMATOMA 16 0.0006
417 GASTROENTERITIS 9 0.0006
418 PLATELET COUNT INCREASED 8 0.0006
419 DECUBITUS ULCER 5 0.0006
420 RENAL CELL CARCINOMA 3 0.0006
421 POLYP 4 0.0006
422 SPEECH DISORDER 32 0.0006
423 CARDIOMYOPATHY 9 0.0006
424 GASTRITIS 16 0.0006
425 PULMONARY CONGESTION 8 0.0006
426 CORONAVIRUS INFECTION 4 0.0006
427 EYELID OEDEMA 7 0.0006
428 DEHYDRATION 80 0.0006
429 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
430 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
431 HAEMODIALYSIS 5 0.0006
432 TOXIC EPIDERMAL NECROLYSIS 9 0.0006
433 NEUTROPHIL COUNT DECREASED 24 0.0006
434 ENDOCARDITIS 3 0.0006
435 EYE MOVEMENT DISORDER 4 0.0006
436 ONYCHOCLASIS 4 0.0006
437 RASH PAPULAR 13 0.0006
438 COGNITIVE DISORDER 27 0.0006
439 PERIORBITAL OEDEMA 3 0.0006
440 DIPLOPIA 15 0.0006
441 PYELONEPHRITIS 5 0.0006
442 ADRENAL INSUFFICIENCY 7 0.0006
443 PULMONARY HYPERTENSION 12 0.0006
444 MEDICATION ERROR 32 0.0006
445 APLASTIC ANAEMIA 3 0.0006
446 RIGHT VENTRICULAR FAILURE 4 0.0006
447 SPINAL OSTEOARTHRITIS 5 0.0006
448 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
449 ANGIOEDEMA 25 0.0006
450 PURPURA 5 0.0006
451 BLINDNESS 23 0.0006
452 HYPOTHYROIDISM 18 0.0006
453 APHASIA 17 0.0006
454 RESPIRATORY FAILURE 41 0.0006
455 BODY HEIGHT DECREASED 6 0.0006
456 CARDIAC FAILURE CONGESTIVE 45 0.0006
457 DISTURBANCE IN ATTENTION 30 0.0006
458 GINGIVITIS 3 0.0006
459 ANAL INCONTINENCE 5 0.0006
460 CATARACT 33 0.0006
461 GASTRIC DISORDER 19 0.0006
462 BLOOD PRESSURE ABNORMAL 11 0.0006
463 FAECES SOFT 4 0.0005
464 RENAL FAILURE 73 0.0005
465 CHOLELITHIASIS 18 0.0005
466 EXOSTOSIS 5 0.0005
467 FAECALOMA 3 0.0005
468 MOUTH HAEMORRHAGE 4 0.0005
469 CARDIAC ARREST 45 0.0005
470 RETINAL DETACHMENT 5 0.0005
471 BLINDNESS TRANSIENT 4 0.0005
472 NECROSIS 3 0.0005
473 DECREASED APPETITE 125 0.0005
474 HEPATIC ENCEPHALOPATHY 5 0.0005
475 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
476 HYDRONEPHROSIS 4 0.0005
477 FACE OEDEMA 9 0.0005
478 HEPATIC FAILURE 16 0.0005
479 BLOOD SODIUM DECREASED 10 0.0005
480 MITRAL VALVE INCOMPETENCE 6 0.0005
481 ENCEPHALOPATHY 13 0.0005
482 SOPOR 7 0.0005
483 GENERAL PHYSICAL HEALTH DETERIORATION 61 0.0005
484 GRANULOCYTOPENIA 3 0.0005
485 PROTEINURIA 10 0.0005
486 DISSOCIATION 4 0.0005
487 MULTI-ORGAN FAILURE 9 0.0005
488 EATING DISORDER 11 0.0005
489 NERVOUS SYSTEM DISORDER 16 0.0005
490 HEPATOMEGALY 5 0.0005
491 PRURITUS GENERALISED 11 0.0005
492 COVID-19 PNEUMONIA 6 0.0005
493 PROSTATIC SPECIFIC ANTIGEN INCREASED 7 0.0005
494 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
495 URINARY INCONTINENCE 15 0.0005
496 OBESITY 8 0.0005
497 NEPHROLITHIASIS 23 0.0005
498 MOBILITY DECREASED 36 0.0005
499 HEPATITIS B 3 0.0005
500 OEDEMA 27 0.0005
501 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
502 TACHYCARDIA 44 0.0005
503 MYASTHENIA GRAVIS 4 0.0005
504 SEASONAL ALLERGY 7 0.0005
505 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
506 MUSCLE DISORDER 4 0.0005
507 END STAGE RENAL DISEASE 9 0.0005
508 INGUINAL HERNIA 3 0.0005
509 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
510 HICCUPS 4 0.0005
511 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
512 HYPERTHYROIDISM 7 0.0005
513 OLIGURIA 3 0.0005
514 ACUTE CORONARY SYNDROME 4 0.0005
515 EMBOLISM 4 0.0005
516 EPISTAXIS 36 0.0005
517 DISORIENTATION 19 0.0005
518 CEREBRAL HAEMORRHAGE 17 0.0005
519 CARDIOVASCULAR DISORDER 12 0.0005
520 PULMONARY MASS 7 0.0005
521 COLON CANCER 7 0.0005
522 PLATELET COUNT DECREASED 50 0.0005
523 ENTERITIS 3 0.0005
524 GLAUCOMA 9 0.0005
525 ANAEMIA 89 0.0005
526 HAEMOGLOBIN ABNORMAL 3 0.0005
527 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
528 ERUCTATION 9 0.0005
529 SKIN ULCER 12 0.0005
530 CONSTIPATION 101 0.0005
531 HYPERTENSION 98 0.0005
532 PALPITATIONS 54 0.0005
533 BRADYPHRENIA 3 0.0005
534 TUMOUR LYSIS SYNDROME 4 0.0005
535 CARDIO-RESPIRATORY ARREST 19 0.0005
536 HAEMATOCRIT DECREASED 9 0.0005
537 RESPIRATORY RATE INCREASED 4 0.0005
538 NERVE INJURY 5 0.0004
539 HAEMOLYTIC ANAEMIA 4 0.0004
540 PAIN OF SKIN 12 0.0004
541 ASCITES 13 0.0004
542 IMPAIRED GASTRIC EMPTYING 6 0.0004
543 RENAL INJURY 13 0.0004
544 ECCHYMOSIS 3 0.0004
545 TINNITUS 20 0.0004
546 UROSEPSIS 4 0.0004
547 LARGE INTESTINE POLYP 3 0.0004
548 MENTAL STATUS CHANGES 12 0.0004
549 HUNGER 6 0.0004
550 FALL 143 0.0004
551 ANAPHYLACTIC SHOCK 11 0.0004
552 HYPOXIA 15 0.0004
553 PAPULE 3 0.0004
554 HEPATIC CIRRHOSIS 8 0.0004
555 STAPHYLOCOCCAL INFECTION 14 0.0004
556 RASH PRURITIC 23 0.0004
557 PULMONARY TOXICITY 3 0.0004
558 HYPOTENSION 85 0.0004
559 FOOT FRACTURE 8 0.0004
560 ABDOMINAL DISTENSION 44 0.0004
561 LIP SWELLING 14 0.0004
562 COAGULOPATHY 7 0.0004
563 COMA 20 0.0004
564 ACCIDENTAL UNDERDOSE 6 0.0004
565 MYELOSUPPRESSION 15 0.0004
566 WEIGHT DECREASED 116 0.0004
567 ACCIDENTAL OVERDOSE 15 0.0004
568 PNEUMONIA 132 0.0004
569 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
570 FLATULENCE 23 0.0004
571 STEVENS-JOHNSON SYNDROME 9 0.0004
572 LIGAMENT SPRAIN 4 0.0004
573 OSTEONECROSIS OF JAW 10 0.0004
574 SEPSIS 45 0.0004
575 BLADDER DISORDER 4 0.0004
576 PNEUMONIA ASPIRATION 10 0.0004
577 EMPHYSEMA 4 0.0004
578 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
579 HYPOTHERMIA 4 0.0004
580 HAEMOPTYSIS 11 0.0004
581 HYPOPHAGIA 10 0.0004
582 DEVICE RELATED INFECTION 6 0.0004
583 HAEMOGLOBIN DECREASED 40 0.0004
584 PERICARDIAL EFFUSION 9 0.0004
585 RIB FRACTURE 8 0.0004
586 ANOREXIA 5 0.0004
587 TEMPERATURE INTOLERANCE 4 0.0004
588 EYE PRURITUS 13 0.0004
589 LEUKOCYTOSIS 7 0.0004
590 OSTEOMYELITIS 7 0.0004
591 HYPERBILIRUBINAEMIA 4 0.0004
592 INJECTION SITE INDURATION 5 0.0004
593 PELVIC FRACTURE 3 0.0004
594 VOMITING 181 0.0004
595 DEAFNESS 10 0.0004
596 ORAL CANDIDIASIS 5 0.0004
597 MOUTH ULCERATION 8 0.0004
598 PULMONARY OEDEMA 17 0.0004
599 SCRATCH 4 0.0004
600 PNEUMOTHORAX 6 0.0004
601 SUDDEN DEATH 4 0.0004
602 FEBRILE NEUTROPENIA 25 0.0004
603 MIOSIS 3 0.0004
604 DIZZINESS 186 0.0004
605 DYSARTHRIA 14 0.0004
606 CHEST DISCOMFORT 38 0.0004
607 GASTROINTESTINAL HAEMORRHAGE 31 0.0004
608 HEART RATE DECREASED 13 0.0004
609 URINARY TRACT INFECTION 63 0.0004
610 TACHYPNOEA 5 0.0004
611 PNEUMONITIS 10 0.0004
612 ACUTE RESPIRATORY FAILURE 7 0.0004
613 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
614 MUSCULAR WEAKNESS 41 0.0004
615 ARRHYTHMIA 17 0.0004
616 CELLULITIS 18 0.0004
617 HYPERHIDROSIS 46 0.0004
618 NEPHROPATHY TOXIC 4 0.0004
619 SENSATION OF FOREIGN BODY 3 0.0004
620 CHROMATURIA 8 0.0004
621 HEPATOCELLULAR INJURY 5 0.0004
622 HEPATITIS 9 0.0004
623 SCAB 4 0.0004
624 CARDIAC OPERATION 3 0.0003
625 HEAD INJURY 11 0.0003
626 INTENTIONAL SELF-INJURY 7 0.0003
627 SKIN SWELLING 3 0.0003
628 CHEST PAIN 64 0.0003
629 BONE MARROW FAILURE 7 0.0003
630 HAEMATOCHEZIA 19 0.0003
631 DISCOMFORT 21 0.0003
632 POST PROCEDURAL HAEMORRHAGE 4 0.0003
633 SPINAL PAIN 4 0.0003
634 AMNESIA 22 0.0003
635 THIRST 6 0.0003
636 LOSS OF CONSCIOUSNESS 43 0.0003
637 ABDOMINAL PAIN UPPER 69 0.0003
638 ASTHENIA 126 0.0003
639 BLOOD PRESSURE INCREASED 51 0.0003
640 BLOOD PRESSURE FLUCTUATION 8 0.0003
641 PYREXIA 115 0.0003
642 OROPHARYNGEAL DISCOMFORT 3 0.0003
643 ABDOMINAL PAIN 77 0.0003
644 LETHARGY 19 0.0003
645 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
646 RESPIRATORY ARREST 9 0.0003
647 IRON DEFICIENCY ANAEMIA 3 0.0003
648 INJECTION SITE EXTRAVASATION 4 0.0003
649 FEMUR FRACTURE 10 0.0003
650 WHITE BLOOD CELL COUNT DECREASED 35 0.0003
651 EJECTION FRACTION DECREASED 5 0.0003
652 BACTERIAL INFECTION 6 0.0003
653 HALLUCINATION 24 0.0003
654 LEUKAEMIA 3 0.0003
655 BLOOD URINE PRESENT 6 0.0003
656 GASTRIC CANCER 8 0.0003
657 MUSCLE ATROPHY 4 0.0003
658 TOXICITY TO VARIOUS AGENTS 53 0.0003
659 INTRAOCULAR PRESSURE INCREASED 4 0.0003
660 POLLAKIURIA 13 0.0003
661 DRUG RESISTANCE 8 0.0003
662 DIZZINESS POSTURAL 3 0.0003
663 NAUSEA 244 0.0003
664 DEEP VEIN THROMBOSIS 20 0.0003
665 RESPIRATORY TRACT INFECTION 8 0.0003
666 DIARRHOEA 198 0.0003
667 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
668 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
669 ABDOMINAL DISCOMFORT 51 0.0003
670 THROMBOCYTOPENIA 34 0.0003
671 HEART RATE INCREASED 30 0.0003
672 HYPOACUSIS 13 0.0003
673 ADVERSE REACTION 4 0.0003
674 EYE HAEMORRHAGE 4 0.0003
675 GASTROOESOPHAGEAL REFLUX DISEASE 24 0.0003
676 MYOCARDIAL INFARCTION 52 0.0003
677 INJECTION SITE MASS 11 0.0003
678 PRODUCT ADMINISTRATION ERROR 6 0.0003
679 FEEDING DISORDER 6 0.0003
680 SLUGGISHNESS 3 0.0003
681 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
682 SKIN LESION 8 0.0003
683 PRURITUS 112 0.0003
684 PERIPHERAL COLDNESS 4 0.0003
685 BLADDER CANCER 17 0.0003
686 PETECHIAE 3 0.0003
687 DERMATITIS 6 0.0003
688 MASS 4 0.0003
689 DYSPHAGIA 27 0.0003
690 INCONTINENCE 3 0.0003
691 DIALYSIS 4 0.0003
692 BREAST PAIN 3 0.0003
693 STOMATITIS 17 0.0003
694 CONVULSION 16 0.0003
695 PARALYSIS 4 0.0003
696 PANCREATIC CARCINOMA 8 0.0003
697 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
698 TOOTHACHE 5 0.0003
699 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
700 OESOPHAGITIS 3 0.0003
701 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
702 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
703 VISUAL ACUITY REDUCED 9 0.0003
704 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
705 IMMUNODEFICIENCY 4 0.0003
706 SKIN INFECTION 3 0.0003
707 VISUAL IMPAIRMENT 33 0.0003
708 BLOOD POTASSIUM DECREASED 8 0.0003
709 FRACTURE 5 0.0003
710 HEPATIC ENZYME INCREASED 18 0.0003
711 SUICIDE ATTEMPT 16 0.0003
712 CHOLECYSTECTOMY 3 0.0003
713 SLEEP APNOEA SYNDROME 5 0.0003
714 MYOCARDITIS 3 0.0003
715 POST PROCEDURAL COMPLICATION 5 0.0003
716 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
717 DRY MOUTH 21 0.0003
718 RENAL DISORDER 12 0.0003
719 KIDNEY INFECTION 5 0.0003
720 CYANOSIS 4 0.0003
721 CYSTITIS 8 0.0003
722 RASH ERYTHEMATOUS 12 0.0003
723 UPPER LIMB FRACTURE 5 0.0003
724 PRESCRIBED UNDERDOSE 5 0.0003
725 POLYNEUROPATHY 3 0.0003
726 WEIGHT INCREASED 56 0.0002
727 INTENTIONAL OVERDOSE 16 0.0002
728 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
729 VISION BLURRED 34 0.0002
730 NEURALGIA 6 0.0002
731 VERTIGO 15 0.0002
732 RED BLOOD CELL COUNT DECREASED 7 0.0002
733 SMALL INTESTINAL OBSTRUCTION 3 0.0002
734 SPINAL OPERATION 3 0.0002
735 EYE DISORDER 8 0.0002
736 DRUG DOSE OMISSION 40 0.0002
737 PHARYNGITIS 3 0.0002
738 LEUKOPENIA 12 0.0002
739 SECRETION DISCHARGE 3 0.0002
740 DYSPNOEA EXERTIONAL 9 0.0002
741 DRUG INTOLERANCE 23 0.0002
742 CANDIDA INFECTION 4 0.0002
743 INJECTION SITE IRRITATION 3 0.0002
744 RASH GENERALISED 6 0.0002
745 DELIRIUM 8 0.0002
746 PRODUCTIVE COUGH 11 0.0002
747 MUCOSAL INFLAMMATION 6 0.0002
748 COMPLETED SUICIDE 19 0.0002
749 DYSPNOEA 129 0.0002
750 ANKYLOSING SPONDYLITIS 3 0.0002
751 HERPES ZOSTER 13 0.0002
752 EAR INFECTION 6 0.0002
753 MALIGNANT MELANOMA 3 0.0002
754 GASTROENTERITIS VIRAL 4 0.0002
755 LIMB INJURY 6 0.0002
756 PALLOR 6 0.0002
757 HYPOAESTHESIA 33 0.0002
758 DRUG EFFECT INCOMPLETE 8 0.0002
759 DRUG TOXICITY 3 0.0002
760 DEPRESSION 50 0.0002
761 GINGIVAL BLEEDING 3 0.0002
762 ACUTE HEPATIC FAILURE 3 0.0002
763 BACK PAIN 51 0.0002
764 MYALGIA 37 0.0002
765 FEELING COLD 6 0.0002
766 ROAD TRAFFIC ACCIDENT 9 0.0002
767 COORDINATION ABNORMAL 3 0.0002
768 INFECTION 31 0.0002
769 IMPAIRED HEALING 7 0.0002
770 OSTEOARTHRITIS 9 0.0002
771 SINUS TACHYCARDIA 3 0.0002
772 INCREASED APPETITE 4 0.0002
773 LOWER LIMB FRACTURE 4 0.0002
774 LOCALISED INFECTION 5 0.0002
775 CEREBROVASCULAR ACCIDENT 35 0.0002
776 FLUID OVERLOAD 3 0.0002
777 EAR PAIN 4 0.0002
778 INTENTIONAL PRODUCT MISUSE 18 0.0002
779 MALAISE 90 0.0002
780 ORAL HERPES 4 0.0002
781 SKIN HAEMORRHAGE 3 0.0002
782 ABASIA 5 0.0002
783 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
784 PERIPHERAL SWELLING 31 0.0002
785 CONDITION AGGRAVATED 61 0.0002
786 THROMBOSIS 16 0.0002
787 OFF LABEL USE 174 0.0002
788 PANCYTOPENIA 11 0.0002
789 MEMORY IMPAIRMENT 27 0.0002
790 INSURANCE ISSUE 3 0.0002
791 BLISTER 11 0.0002
792 INSOMNIA 52 0.0002
793 PHARYNGEAL OEDEMA 3 0.0002
794 ERECTILE DYSFUNCTION 5 0.0002
795 ERYTHEMA 40 0.0002
796 LIMB DISCOMFORT 6 0.0002
797 ANKLE FRACTURE 3 0.0002
798 COVID-19 34 0.0002
799 CONFUSIONAL STATE 31 0.0002
800 UNDERDOSE 14 0.0002
801 ECZEMA 10 0.0002
802 DISEASE RECURRENCE 9 0.0002
803 RESPIRATORY TRACT CONGESTION 3 0.0002
804 MIGRAINE 18 0.0002
805 INFLUENZA 21 0.0002
806 SCIATICA 3 0.0002
807 ABSCESS 3 0.0002
808 INJECTION SITE HAEMORRHAGE 15 0.0002
809 DRY SKIN 25 0.0002
810 MOVEMENT DISORDER 6 0.0002
811 FREQUENT BOWEL MOVEMENTS 5 0.0002
812 COLITIS 7 0.0002
813 FAECES DISCOLOURED 4 0.0002
814 METASTASES TO BONE 3 0.0002
815 RESPIRATORY DISTRESS 5 0.0002
816 ANAPHYLACTIC REACTION 10 0.0002
817 NEUROPATHY PERIPHERAL 17 0.0002
818 THERAPY NON-RESPONDER 8 0.0002
819 OXYGEN SATURATION DECREASED 10 0.0002
820 GAIT DISTURBANCE 34 0.0002
821 PRODUCT USE IN UNAPPROVED INDICATION 44 0.0002
822 HEART RATE IRREGULAR 4 0.0002
823 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
824 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
825 PRODUCT USE ISSUE 33 0.0002
826 SOMNOLENCE 35 0.0002
827 NASOPHARYNGITIS 32 0.0002
828 MUSCULOSKELETAL PAIN 9 0.0002
829 DYSSTASIA 5 0.0002
830 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
831 METASTASES TO LIVER 3 0.0002
832 MUSCLE SPASMS 31 0.0002
833 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
834 LACRIMATION INCREASED 5 0.0002
835 MENTAL IMPAIRMENT 4 0.0002
836 RESTLESS LEGS SYNDROME 3 0.0002
837 FIBROMYALGIA 4 0.0002
838 PRESYNCOPE 4 0.0002
839 SEIZURE 19 0.0002
840 INJECTION SITE PRURITUS 11 0.0002
841 DRUG ADMINISTRATION ERROR 5 0.0002
842 CHILLS 19 0.0002
843 URTICARIA 27 0.0002
844 CARDIAC DISORDER 15 0.0002
845 SWOLLEN TONGUE 5 0.0002
846 ARTHRALGIA 66 0.0002
847 RASH 69 0.0002
848 PULMONARY EMBOLISM 15 0.0002
849 COUGH 44 0.0002
850 PAIN IN EXTREMITY 46 0.0002
851 SINUSITIS 16 0.0002
852 DRUG DEPENDENCE 25 0.0002
853 HAEMORRHOIDS 3 0.0002
854 PRODUCT DOSE OMISSION 10 0.0002
855 INJECTION SITE ERYTHEMA 19 0.0002
856 DYSPEPSIA 15 0.0002
857 WHEEZING 9 0.0002
858 DISABILITY 3 0.0002
859 PANCREATITIS 8 0.0002
860 TREMOR 25 0.0002
861 FUNGAL INFECTION 5 0.0001
862 AGITATION 11 0.0001
863 SPINAL FRACTURE 3 0.0001
864 PRODUCT PHYSICAL ISSUE 3 0.0001
865 BRONCHITIS 11 0.0001
866 THERAPEUTIC RESPONSE DECREASED 9 0.0001
867 THROAT TIGHTNESS 4 0.0001
868 FLUSHING 15 0.0001
869 DEVICE ISSUE 13 0.0001
870 PERITONITIS 3 0.0001
871 INCORRECT DOSE ADMINISTERED 33 0.0001
872 ASTHMA 16 0.0001
873 LYMPHADENOPATHY 5 0.0001
874 RECTAL HAEMORRHAGE 6 0.0001
875 HYPERSOMNIA 4 0.0001
876 POOR QUALITY SLEEP 3 0.0001
877 SWELLING FACE 9 0.0001
878 FLUID RETENTION 7 0.0001
879 ALOPECIA 27 0.0001
880 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
881 ANXIETY 39 0.0001
882 RESTLESSNESS 5 0.0001
883 INFLAMMATION 7 0.0001
884 SNEEZING 3 0.0001
885 RESPIRATORY DISORDER 4 0.0001
886 TREATMENT FAILURE 11 0.0001
887 NEUTROPENIA 18 0.0001
888 FATIGUE 103 0.0001
889 UNEVALUABLE EVENT 10 0.0001
890 EMOTIONAL DISORDER 4 0.0001
891 GYNAECOMASTIA 4 0.0001
892 HYPERSENSITIVITY 24 0.0001
893 PRODUCT DOSE OMISSION ISSUE 38 0.0001
894 EXPOSURE DURING PREGNANCY 8 0.0001
895 BLOOD CHOLESTEROL INCREASED 6 0.0001
896 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
897 TREATMENT NONCOMPLIANCE 7 0.0001
898 BALANCE DISORDER 11 0.0001
899 ARTHRITIS 10 0.0001
900 PRODUCT PRESCRIBING ERROR 3 0.0001
901 ARTHROPATHY 7 0.0001
902 NECK PAIN 7 0.0001
903 CONTUSION 12 0.0001
904 HIP FRACTURE 4 0.0001
905 NIGHT SWEATS 4 0.0001
906 RHINORRHOEA 8 0.0001
907 DRUG INEFFECTIVE 162 0.0001
908 LUNG DISORDER 6 0.0001
909 INFLUENZA LIKE ILLNESS 10 0.0001
910 DYSGEUSIA 9 0.0001
911 EXPIRED PRODUCT ADMINISTERED 4 0.0001
912 AGEUSIA 3 0.0001
913 VIRAL INFECTION 4 0.0001
914 GAIT INABILITY 4 0.0001
915 BONE PAIN 7 0.0001
916 DISEASE PROGRESSION 14 0.0001
917 PRODUCT QUALITY ISSUE 16 0.0001
918 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
919 SWELLING 11 0.0001
920 HOSPITALISATION 18 0.0001
921 FEELING ABNORMAL 28 0.0001
922 HEADACHE 73 0.0001
923 JOINT SWELLING 14 0.0001
924 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
925 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
926 MUSCULOSKELETAL STIFFNESS 10 0.0001
927 BURNING SENSATION 8 0.0001
928 INJURY 8 0.0001
929 INJECTION SITE BRUISING 9 0.0001
930 DRUG EFFECT DECREASED 6 0.0001
931 PAIN 68 0.0001
932 PANIC ATTACK 4 0.0001
933 PARAESTHESIA 17 0.0001
934 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
935 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
936 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
937 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 19 0.0001
938 OCULAR HYPERAEMIA 5 0.0001
939 HAEMORRHAGE 11 0.0001
940 NEOPLASM MALIGNANT 7 0.0001
941 MULTIPLE SCLEROSIS 5 0.0001
942 INJECTION SITE SWELLING 8 0.0001
943 ILL-DEFINED DISORDER 6 0.0001
944 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
945 PSORIATIC ARTHROPATHY 4 0.0001
946 FEELING HOT 6 0.0001
947 INJECTION SITE RASH 3 0.0001
948 LUNG NEOPLASM MALIGNANT 4 0.0001
949 DEPRESSED MOOD 5 0.0001
950 OVERDOSE 20 0.0001
951 DEVICE LEAKAGE 4 0.0001
952 PRODUCT STORAGE ERROR 8 0.0001
953 INJECTION SITE PAIN 27 0.0001
954 ILLNESS 9 0.0001
955 PROSTATE CANCER 7 0.0001
956 NIGHTMARE 3 0.0001
957 NEOPLASM PROGRESSION 3 0.0001
958 RASH MACULAR 3 0.0001
959 DYSPHONIA 5 0.0001
960 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
961 SKIN EXFOLIATION 7 0.0001
962 DRY EYE 4 0.0001
963 ADVERSE DRUG REACTION 7 0.0001
964 PLASMA CELL MYELOMA 3 0.0001
965 ABNORMAL BEHAVIOUR 3 0.0001
966 OROPHARYNGEAL PAIN 7 0.0001
967 BREAST CANCER 7 0.0001
968 DYSKINESIA 3 0.0001
969 EYE PAIN 4 0.0001
970 EYE IRRITATION 4 0.0001
971 PRODUCT SUBSTITUTION ISSUE 4 0.0001
972 MENTAL DISORDER 3 0.0001
973 SURGERY 4 0.0001
974 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
975 DEATH 57 0.0001
976 SUICIDAL IDEATION 6 0.0001
977 SKIN DISCOLOURATION 3 0.0001
978 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
979 RHEUMATOID ARTHRITIS 7 0.0001
980 INFUSION RELATED REACTION 4 0.0001
981 NERVOUSNESS 3 0.0001
982 SLEEP DISORDER 4 0.0001
983 ADVERSE EVENT 5 0.0001
984 HOT FLUSH 4 0.0001
985 IRRITABILITY 3 0.0000
986 NO ADVERSE EVENT 9 0.0000
987 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
988 DRUG ABUSE 4 0.0000
989 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
990 INJECTION SITE REACTION 3 0.0000
991 DEVICE MALFUNCTION 3 0.0000
992 ACNE 3 0.0000
993 PSORIASIS 5 0.0000
994 EMOTIONAL DISTRESS 4 0.0000